Wahed Invest LLC Regeneron Pharmaceuticals, Inc. Transaction History

Wahed Invest LLC

$555 Million
Q3 2024

A detailed history of Wahed Invest LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wahed Invest LLC holds 2,510 shares of REGN stock, worth $1.79 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

2,510

Previous 2,260 11.06%

Holding current value

$1.79 Million

Previous $2.38 Million 11.07%

% of portfolio

0.48%

Previous 0.48%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $256,022 - $300,440	250 Added 11.06%	2,510 $2.64 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $2 Million - $2.42 Million	2,260 New	2,260 $2.38 Million
Q4 2023 Mar 11, 2024	SELL	$775.18 - $881.7 $797,660 - $907,269	-1,029 Reduced 37.07%	1,747 $1.53 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $889,906 - $1.01 Million	1,148 Added 70.52%	2,776 $2.44 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $99,020 - $120,744	143 Added 9.63%	1,628 $1.34 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $107,804 - $127,873	154 Added 11.57%	1,485 $1.07 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $4,763 - $5,788	7 Added 0.53%	1,331 $1.09 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $100,942 - $109,593	143 Added 12.11%	1,324 $955,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $41,325 - $52,151	72 Added 6.49%	1,181 $814,000
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $52,093 - $70,189	-95 Reduced 7.89%	1,109 $656,000
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $2,975 - $3,492	5 Added 0.42%	1,204 $841,000
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $651,632 - $804,493	1,199 New	1,199 $757,000

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wahed Invest LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wahed Invest LLC with notifications on news.

Account